Skip to main content
Journal cover image

Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.

Publication ,  Journal Article
Kobe, EA; Edelman, D; Tarkington, PE; Bosworth, HB; Maciejewski, ML; Steinhauser, K; Jeffreys, AS; Coffman, CJ; Smith, VA; Strawbridge, EM ...
Published in: Contemp Clin Trials
November 2020

BACKGROUND: Persistent poorly-controlled type 2 diabetes mellitus (PPDM), or maintenance of a hemoglobin A1c (HbA1c) ≥8.5% despite receiving clinic-based diabetes care, contributes disproportionately to the national diabetes burden. Comprehensive telehealth interventions may help ameliorate PPDM, but existing approaches have rarely been designed with clinical implementation in mind, limiting use in routine practice. We describe a study testing a novel telehealth intervention that comprehensively targets clinic-refractory PPDM, and was explicitly developed for practical delivery using existing Veterans Health Administration (VHA) clinical infrastructure. METHODS: Practical Telehealth to Improve Control and Engagement for Patients with Clinic-Refractory Diabetes Mellitus (PRACTICE-DM) is an ongoing randomized controlled trial comparing two 12-month interventions: 1) standard VHA Home Telehealth (HT) telemonitoring/care coordination; or 2) the PRACTICE-DM intervention, a comprehensive HT-delivered intervention combining telemonitoring, self-management support, diet/activity support, medication management, and depression management. The primary outcome is HbA1c. Secondary outcomes include diabetes distress, self-care, self-efficacy, weight, depressive symptoms, implementation barriers/facilitators, and costs. We hypothesize that the PRACTICE-DM intervention will reduce HbA1c by >0.6% versus standard HT over 12 months. RESULTS: Enrollment for this ongoing trial concluded in January 2020; 200 patients were randomized (99 to standard HT and 101 to the PRACTICE-DM intervention). The cohort has a mean age of 58 and is 23% female and 72% African American. Mean baseline HbA1c and BMI were 10.2% and 34.8 kg/m2. CONCLUSIONS: Because it comprehensively targets factors underlying PPDM using existing clinical infrastructure, the PRACTICE-DM intervention may be well suited to lower the complications and costs of PPDM in routine practice.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

November 2020

Volume

98

Start / End Page

106157

Location

United States

Related Subject Headings

  • Telemedicine
  • Self Efficacy
  • Self Care
  • Randomized Controlled Trials as Topic
  • Public Health
  • Male
  • Humans
  • Glycated Hemoglobin
  • General Clinical Medicine
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kobe, E. A., Edelman, D., Tarkington, P. E., Bosworth, H. B., Maciejewski, M. L., Steinhauser, K., … Crowley, M. J. (2020). Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial. Contemp Clin Trials, 98, 106157. https://doi.org/10.1016/j.cct.2020.106157
Kobe, Elizabeth A., David Edelman, Phillip E. Tarkington, Hayden B. Bosworth, Matthew L. Maciejewski, Karen Steinhauser, Amy S. Jeffreys, et al. “Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.Contemp Clin Trials 98 (November 2020): 106157. https://doi.org/10.1016/j.cct.2020.106157.
Kobe EA, Edelman D, Tarkington PE, Bosworth HB, Maciejewski ML, Steinhauser K, et al. Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial. Contemp Clin Trials. 2020 Nov;98:106157.
Kobe, Elizabeth A., et al. “Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.Contemp Clin Trials, vol. 98, Nov. 2020, p. 106157. Pubmed, doi:10.1016/j.cct.2020.106157.
Kobe EA, Edelman D, Tarkington PE, Bosworth HB, Maciejewski ML, Steinhauser K, Jeffreys AS, Coffman CJ, Smith VA, Strawbridge EM, Szabo ST, Desai S, Garrett MP, Wilmot TC, Marcano TJ, Overby DL, Tisdale GA, Durkee M, Bullard S, Dar MS, Mundy AC, Hiner J, Fredrickson SK, Majette Elliott NT, Howard T, Jeter DH, Danus S, Crowley MJ. Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial. Contemp Clin Trials. 2020 Nov;98:106157.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

November 2020

Volume

98

Start / End Page

106157

Location

United States

Related Subject Headings

  • Telemedicine
  • Self Efficacy
  • Self Care
  • Randomized Controlled Trials as Topic
  • Public Health
  • Male
  • Humans
  • Glycated Hemoglobin
  • General Clinical Medicine
  • Female